Predictions
Bausch Health Companies Inc.
Start price
Target price
Perf. (%)
€6.63
05.09.22
05.09.22
-
05.09.23
05.09.23
15.97%
06.09.23
06.09.23
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.18
04.09.22
04.09.22
-
04.09.23
04.09.23
-9.84%
01.10.22
01.10.22
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.30
26.08.22
26.08.22
-
26.08.23
26.08.23
-4.98%
03.09.22
03.09.22
Canopy Growth Corp
Start price
Target price
Perf. (%)
€4.29
26.08.22
26.08.22
€6.00
26.08.23
26.08.23
-41.69%
13.10.22
13.10.22
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€7.85
24.08.22
24.08.22
-
24.08.23
24.08.23
-10.03%
03.09.22
03.09.22
Could be worthwhile Investment >10% per year
Bausch Health Companies Inc.
Start price
Target price
Perf. (%)
€5.40
23.08.22
23.08.22
-
23.08.23
23.08.23
29.96%
09.09.22
09.09.22
Capable Management
Probably not worthwhile Investment
Revenue decline/stagnation expected
Aphria Inc.
Start price
Target price
Perf. (%)
€12.71
08.08.22
08.08.22
-
08.08.26
08.08.26
-
11.03.24
11.03.24
Could be worthwhile Investment >10% per year
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.39
03.08.22
03.08.22
€2.80
03.08.23
03.08.23
-14.19%
20.09.22
20.09.22
Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Canopy Growth Corp
Start price
Target price
Perf. (%)
€2.91
03.08.22
03.08.22
€3.30
03.08.23
03.08.23
-12.37%
13.10.22
13.10.22
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Risky balance sheet
Helius Medical Technologies Inc
Start price
Target price
Perf. (%)
€1.85
03.08.22
03.08.22
-
03.08.23
03.08.23
-92.76%
14.05.23
14.05.23
Bausch Health Companies Inc.
Start price
Target price
Perf. (%)
€4.11
28.07.22
28.07.22
-
28.07.23
28.07.23
35.16%
14.05.23
14.05.23
Organigram Holdings Inc.
Start price
Target price
Perf. (%)
€4.16
24.07.22
24.07.22
-
24.07.23
24.07.23
-2.64%
04.09.22
04.09.22
Promis Neurosciences Inc.
Start price
Target price
Perf. (%)
€5.37
21.07.22
21.07.22
€5.30
21.07.23
21.07.23
-21.42%
11.03.23
11.03.23
ROE lower than 10% per year
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Bausch Health Companies Inc.
Start price
Target price
Perf. (%)
€8.45
11.07.22
11.07.22
-
11.07.23
11.07.23
-39.77%
04.08.22
04.08.22
Capable Management
Probably not worthwhile Investment
Revenue decline/stagnation expected
Organigram Holdings Inc.
Start price
Target price
Perf. (%)
€4.09
10.07.22
10.07.22
-
10.07.23
10.07.23
1.76%
23.07.22
23.07.22
Promis Neurosciences Inc.
Start price
Target price
Perf. (%)
€8.93
09.07.22
09.07.22
€4.00
09.07.23
09.07.23
-40.65%
23.07.22
23.07.22
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€10.81
04.07.22
04.07.22
-
04.07.23
04.07.23
-24.63%
06.08.22
06.08.22
Could be worthwhile Investment >10% per year
Organigram Holdings Inc.
Start price
Target price
Perf. (%)
€4.27
27.06.22
27.06.22
-
27.06.23
27.06.23
-4.35%
09.07.22
09.07.22